Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 841 AL 855

Are vascular factors linked to the development of hippocampal atrophy in Alzheimer's disease?

Dhikav V, Anand KS.

J Alzheimers Dis. 2012;32(3):711-8. doi: 10.3233/JAD-2012-120928.

Neuropsychiatric symptoms in mild dementia with lewy bodies and Alzheimer's disease

Bjoerke-Bertheussen J, Ehrt U, Rongve A, Ballard C, Aarsland D.

Dement Geriatr Cogn Disord. 2012;34(1):1-6. doi: 10.1159/000339590. Epub 2012 Jul 31.

Using blood markers for Alzheimer disease in clinical practice?

O'Bryant SE.

Neurology. 2012 Aug 28;79(9):846-7. doi: 10.1212/WNL.0b013e318266fd21. Epub 2012 Aug 1.

Alzheimer's disease in a dish: promises and challenges of human stem cell models

Young JE, Goldstein LS.

Hum Mol Genet. 2012 Oct 15;21(R1):R82-9. doi: 10.1093/hmg/dds319. Epub 2012 Aug 2.

Nonamnestic presentations of early-onset Alzheimer's disease

Mendez MF, Lee AS, Karve SJ, Shapira JS.

Am J Alzheimers Dis Other Demen. 2012 Sep;27(6):413-20. doi: 10.1177/1533317512454711. Epub 2012 Aug 7.

[Physical exercise in patients with dementia]

Zieschang T, Hauer K, Schwenk M.

Dtsch Med Wochenschr. 2012 Aug;137(31-32):1552-5. doi: 10.1055/s-0032-1305114. Epub 2012 Aug 7.

Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors

Catindig JA, Venketasubramanian N, Ikram MK, Chen C.

J Neurol Sci. 2012 Oct 15;321(1-2):11-6. doi: 10.1016/j.jns.2012.07.023. Epub 2012 Aug 9.

A systematic review of screening tools for predicting the development of dementia

Lischka AR, Mendelsohn M, Overend T, Forbes D.

Can J Aging. 2012 Sep;31(3):295-311. doi: 10.1017/S0714980812000220. Epub 2012 Aug 9.

[Pharmacological studies for the ameliorative effects of yokukansan on memory deficits and abnormal behavior in an animal model of dementia]

Iwasaki K, Takasaki K, Nogami A, Kubota K, Katsurabayashi S, Mishima K, Fujiwara M.

Nihon Yakurigaku Zasshi. 2012 Aug;140(2):66-70. doi: 10.1254/fpj.140.66.

Does vascular pathology contribute to Alzheimer changes?

Kalaria RN, Akinyemi R, Ihara M.

J Neurol Sci. 2012 Nov 15;322(1-2):141-7. doi: 10.1016/j.jns.2012.07.032. Epub 2012 Aug 11.

Can the treatment of vascular risk factors slow cognitive decline in Alzheimer's disease patients?

Richard F, Pasquier F.

J Alzheimers Dis. 2012;32(3):765-72. doi: 10.3233/JAD-2012-121012.

Cerebrovascular assessment for the risk prediction of Alzheimer's disease

Silvestrini M, Viticchi G, Altamura C, Luzzi S, Balucani C, Vernieri F.

J Alzheimers Dis. 2012;32(3):689-98. doi: 10.3233/JAD-2012-121240.

Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease

Daulatzai MA.

Neurochem Res. 2012 Dec;37(12):2627-58. doi: 10.1007/s11064-012-0854-6. Epub 2012 Aug 12.

Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease

Chhatwal JP, Sperling RA.

J Alzheimers Dis. 2012;31 Suppl 3(0 3):S155-67. doi: 10.3233/JAD-2012-120730.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias